Showing 1 - 7 results of 7 for search 'Brigitte Le Mauff', query time: 0.04s Refine Results
  1. 1
    Natalizumab in Multiple Sclerosis Treatment: From Biological Effects to Immune Monitoring

    Natalizumab in Multiple Sclerosis Treatment: From Biological Effects to Immune Monitoring by Kathy Khoy, Delphine Mariotte, Gilles Defer, Gilles Defer, Gilles Defer, Gautier Petit, Olivier Toutirais, Olivier Toutirais, Olivier Toutirais, Brigitte Le Mauff, Brigitte Le Mauff, Brigitte Le Mauff

    Published 2020-09-01
    Get full text
    Article
  2. 2
    HLA-Class II Artificial Antigen Presenting Cells in CD4+ T Cell-Based Immunotherapy

    HLA-Class II Artificial Antigen Presenting Cells in CD4+ T Cell-Based Immunotherapy by Alexandre Couture, Anthony Garnier, Fabian Docagne, Olivier Boyer, Denis Vivien, Denis Vivien, Brigitte Le-Mauff, Brigitte Le-Mauff, Jean-Baptiste Latouche, Jean-Baptiste Latouche, Olivier Toutirais, Olivier Toutirais, Olivier Toutirais

    Published 2019-05-01
    Get full text
    Article
  3. 3
    Adenovirus-Mediated CTLA4Ig or CD40Ig Gene Transfer Delays Pancreatic Islet Rejection in a Rat-to-Mouse Xenotransplantation Model after Systemic but Not Local Expression

    Adenovirus-Mediated CTLA4Ig or CD40Ig Gene Transfer Delays Pancreatic Islet Rejection in a Rat-to-Mouse Xenotransplantation Model after Systemic but Not Local Expression by Nicolas Potiron, Carine Chagneau, Françoise Boeffard, Jean-Paul Soulillou, Ignacio Anegon, Brigitte Le Mauff

    Published 2005-05-01
    Get full text
    Article
  4. 4
    Tissue-plasminogen activator effects on the phenotype of splenic myeloid cells in acute inflammation

    Tissue-plasminogen activator effects on the phenotype of splenic myeloid cells in acute inflammation by Célia Seillier, Léonie Lesec, Pauline Hélie, Charlotte Marie, Denis Vivien, Fabian Docagne, Brigitte Le Mauff, Olivier Toutirais

    Published 2024-02-01
    Get full text
    Article
  5. 5
    Validation of an anti-α-Gal IgE fluoroenzyme-immunoassay for the screening of patients at risk of severe anaphylaxis to cetuximab

    Validation of an anti-α-Gal IgE fluoroenzyme-immunoassay for the screening of patients at risk of severe anaphylaxis to cetuximab by Julien Serrier, Jean-Baptiste Davy, Benoît Dupont, Bénédicte Clarisse, Jean-Jacques Parienti, Gautier Petit, Kathy Khoy, Yann Ollivier, Radj Gervais, Delphine Mariotte, Brigitte Le Mauff

    Published 2023-01-01
    Get full text
    Article
  6. 6
    Tissue plasminogen activator worsens experimental autoimmune encephalomyelitis by complementary actions on lymphoid and myeloid cell responses

    Tissue plasminogen activator worsens experimental autoimmune encephalomyelitis by complementary actions on lymphoid and myeloid cell responses by Pauline Hélie, Celia Camacho-Toledano, Léonie Lesec, Célia Seillier, Antonio J. Miralles, Maria Cristina Ortega, Sylvaine Guérit, Héloïse Lebas, Isabelle Bardou, Virginia Vila-del Sol, Denis Vivien, Brigitte Le Mauff, Diego Clemente, Fabian Docagne, Olivier Toutirais

    Published 2021-02-01
    Get full text
    Article
  7. 7
    Disease patterns and specific trajectories of anti-MDA5-related disease: a multicentre retrospective study of 70 adult patients

    Disease patterns and specific trajectories of anti-MDA5-related disease: a multicentre retrospective study of 70 adult patients by Hubert de Boysson, Marie Cuchet, Charles Cassius, Pierre Cuchet, Christian Agard, Alexandra Audemard-Verger, Sylvain Marchand-Adam, Raphaëlla Cohen-Sors, Laure Gallay, Julie Graveleau, Cécile Lesort, Kim Ly, Alain Meyer, Grégoire Monseau, Antoine Néel, Bernard Bonnotte, Laurent Pérard, Nicolas Schleinitz, Delphine Mariotte, Brigitte Le Mauff, Gwladys Bourdenet, Gwladys Bourdenet, Wafa Masmoudi, Samuel Deshayes, Anaël Dumont, Anne Dompmartin, Diane Kottler, Achille Aouba

    Published 2024-01-01
    Get full text
    Article

Search Tools: